{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:39:31Z","timestamp":1790217571128,"version":"4.1.0"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119692","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:36:04Z","timestamp":1781897764000},"page":"119692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The Warburg effect and beyond: Glycolytic reprogramming in cancer progression and emerging therapeutic strategies"],"prefix":"10.1016","volume":"201","author":[{"given":"Yuxuan","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengding","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0436-4277","authenticated-orcid":false,"given":"Wenfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119692_bib1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119692_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119692_bib3","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s42255-024-01121-9","article-title":"Organization of a functional glycolytic metabolon on mitochondria for metabolic efficiency","volume":"6","author":"Wang","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2026.119692_bib4","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1038\/s41467-025-60596-6","article-title":"Self-organizing glycolytic waves tune cellular metabolic states and fuel cancer progression","volume":"16","author":"Zhan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2026.119692_bib6","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1038\/s41467-024-49221-0","article-title":"MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s10565-024-09945-7","article-title":"E2F1-driven CENPM expression promotes glycolytic reprogramming and tumorigenicity in glioblastoma","volume":"41","author":"Yi","year":"2024","journal-title":"Cell. Biol. Toxicol."},{"key":"10.1016\/j.biopha.2026.119692_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-024-02008-9","article-title":"Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119692_bib9","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1","volume":"34","author":"Guo","year":"2022","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119692_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","article-title":"ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer","volume":"41","author":"Dong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119692_bib11","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41467-024-46193-z","article-title":"Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression","volume":"15","author":"Khan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105389","article-title":"Single cell atlas reveals multilayered metabolic heterogeneity across tumour types","volume":"109","author":"Zhou","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2026.119692_bib13","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/s41467-023-38360-5","article-title":"Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41586-022-04758-2","article-title":"PHGDH heterogeneity potentiates cancer cell dissemination and metastasis","volume":"605","author":"Rossi","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119692_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115956","article-title":"Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation","volume":"170","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119692_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","article-title":"We need to talk about the Warburg effect","volume":"2","author":"DeBerardinis","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2026.119692_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12933-024-02458-x","article-title":"Spatial multiomics atlas reveals smooth muscle phenotypic transformation and metabolic reprogramming in diabetic macroangiopathy","volume":"23","author":"Qian","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2026.119692_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119692_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119692_bib20","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/cas.15468","article-title":"Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation","volume":"113","author":"Du","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2026.119692_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1158\/0008-5472.CAN-22-2370","article-title":"PINK1-Mediated Mitophagy Promotes Oxidative Phosphorylation and Redox Homeostasis to Induce Drug-Tolerant Persister Cancer Cells","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119692_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119692_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol33040201","article-title":"Metabolomic Insights into Head and Neck Cancer: Recent Advances and Future Directions","volume":"33","author":"Ponneganti","year":"2026","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.biopha.2026.119692_bib24","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1021\/acs.jpcb.4c03663","article-title":"Kinetic Trajectories of Glucose Uptake in Single Cancer Cells Reveal a Drug-Induced Cell-State Change Within Hours of Drug Treatment","volume":"128","author":"Kim","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.biopha.2026.119692_bib25","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.21037\/jgo-24-560","article-title":"LDHA as a predictive biomarker and its association with the infiltration of immune cells in pancreatic adenocarcinoma","volume":"15","author":"Zheng","year":"2024","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.biopha.2026.119692_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18050735","article-title":"Multi-Omics Characterization of Lactate-Associated Molecular Subtypes in Lung Cancer Suggests a Role for DKK1 in Lactate-Linked Migration, Invasion, and Lactylation Programs","volume":"18","author":"Yu","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2026.119692_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1422281","article-title":"The critical role of glutamine and fatty acids in the metabolic reprogramming of anoikis-resistant melanoma cells","volume":"15","author":"Peppicelli","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119692_bib28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1158\/2159-8290.CD-19-0297","article-title":"Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment","volume":"10","author":"Dey","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2026.119692_bib29","doi-asserted-by":"crossref","unstructured":"G. Unlu, A. Millet, K. Wangdu, R. Donn\u00e9, R. Erdal, N.L. DelGaudio, B. Uygur, V. Shah, K. Cho, A. Fecke, F. Cansiz, Z.C. Tarcan, M. Isay-Del Viscio, E. Kilic, I. Kurth, H. Molina, A. Sickmann, O. Basturk, G. Patti, S. Beyaz, K.W. Smith, A. Lujambio, A. Tasdogan, S.F. Tavazoie, K. Birsoy, Tumor Genotype Dictates Mitochondrial and Immune Vulnerabilities in Liver Cancer, bioRxiv, (2025).","DOI":"10.1101\/2025.09.10.675369"},{"key":"10.1016\/j.biopha.2026.119692_bib30","doi-asserted-by":"crossref","unstructured":"N. Sanghvi, C. Calvo-Alca\u00f1iz, P.S. Rajagopal, S. Scalera, V. Canu, S. Sinha, F. Schischlik, K. Wang, S. Madan, E. Shulman, A. Papanicolau-Sengos, G. Blandino, E. Ruppin, N.U. Nair, Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues, bioRxiv, (2023).","DOI":"10.1101\/2023.10.30.564810"},{"key":"10.1016\/j.biopha.2026.119692_bib31","first-page":"175","article-title":"Frontiers in Mass Spectrometry-Based Spatial Metabolomics: Current Applications and Challenges in the Context of Biomedical Research","author":"Wheeler","year":"2024","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.biopha.2026.119692_bib32","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41592-024-02392-6","article-title":"Integration of mass cytometry and mass spectrometry imaging for spatially resolved single-cell metabolic profiling","volume":"21","author":"Nunes","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2026.119692_bib33","article-title":"Integrated spatial omics of metabolic reprogramming and the tumor microenvironment in pancreatic cancer","volume":"28","author":"Wu","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2026.119692_bib34","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1158\/1078-0432.CCR-21-4383","article-title":"Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients","volume":"28","author":"Wang","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119692_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.04.003","article-title":"Intra-Tumoral Metabolic Zonation and Resultant Phenotypic Diversification Are Dictated by Blood Vessel Proximity","volume":"30","author":"Kumar","year":"2019","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119692_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218557","article-title":"The BTN3A3-TOMM22 axis preserves mitochondrial homeostasis to facilitate HCC stemness and drug resistance","author":"Kang","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119692_bib37","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s12015-025-10956-y","article-title":"Metabolic Plasticity and Cancer Stem Cell Metabolism: Exploring the Glycolysis-OXPHOS Switch as a Mechanism for Resistance and Tumorigenesis","volume":"21","author":"Keoh","year":"2025","journal-title":"Stem Cell. Rev. Rep."},{"key":"10.1016\/j.biopha.2026.119692_bib38","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/neuonc\/noy066","article-title":"Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma","volume":"20","author":"Stadlbauer","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.biopha.2026.119692_bib39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41419-025-07987-1","article-title":"Targeting mitochondrial translation and OXPHOS in high-grade serous ovarian carcinoma eliminates stem-like cells","volume":"16","author":"Narayanan","year":"2025","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119692_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114988","article-title":"ACSS1-dependent acetate utilization rewires mitochondrial metabolism to support AML and melanoma tumor growth and metastasis","volume":"43","author":"Hlavaty","year":"2024","journal-title":"Cell. Rep."},{"key":"10.1016\/j.biopha.2026.119692_bib41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41556-025-01651-8","article-title":"ALDH4A1 functions as an active component of the MPC complex maintaining mitochondrial pyruvate import for TCA cycle entry and tumour suppression","volume":"27","author":"Hsu","year":"2025","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119692_bib42","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022110620","article-title":"IDH2 stabilizes HIF-1\u03b1-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer","volume":"42","author":"Shigeta","year":"2023","journal-title":"Embo J."},{"key":"10.1016\/j.biopha.2026.119692_bib43","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1101\/gad.198200.112","article-title":"D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function","volume":"26","author":"Sasaki","year":"2012","journal-title":"Genes. Dev."},{"key":"10.1016\/j.biopha.2026.119692_bib44","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/ncomms4423","article-title":"Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases","volume":"5","author":"Tarhonskaya","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib45","first-page":"638","article-title":"The SP1\/SNHG16\/GLUT1 axis promotes prostate cancer proliferation and invasion by regulating glucose metabolism","volume":"21","author":"Huang","year":"2025","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.biopha.2026.119692_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12967-023-04805-0","article-title":"PIGT promotes cell growth, glycolysis, and metastasis in bladder cancer by modulating GLUT1 glycosylation and membrane trafficking","volume":"22","author":"Tan","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119692_bib47","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1038\/s41388-023-02760-0","article-title":"Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy","volume":"42","author":"Gao","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119692_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0332825","article-title":"Lactic acid regulates antitumor immunity in canine invasive urothelial carcinoma","volume":"20","author":"Kato","year":"2025","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119692_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111591","article-title":"Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma","volume":"384","author":"Zhao","year":"2019","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.biopha.2026.119692_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217117","article-title":"Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer","volume":"598","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119692_bib51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41467-019-08921-8","article-title":"Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.actbio.2022.12.067","article-title":"Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment","volume":"158","author":"Zhang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2026.119692_bib53","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/s41467-019-10375-x","article-title":"APC\/C(CDH1) synchronizes ribose-5-phosphate levels and DNA synthesis to cell cycle progression","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217633","article-title":"Pentose phosphate recycling driven by Gli1 contributes to chemotherapy resistance in cancer cells","volume":"618","author":"Hu","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119692_bib55","doi-asserted-by":"crossref","first-page":"87623","DOI":"10.18632\/oncotarget.21007","article-title":"Disrupting glucose-6-phosphate isomerase fully suppresses the \"Warburg effect\" and activates OXPHOS with minimal impact on tumor growth except in hypoxia","volume":"8","author":"de Padua","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119692_bib56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/CAD.0000000000001750","article-title":"Discovery and optimization of oxidative phosphorylation inhibitors from a phenotypic screen","volume":"36","author":"Shemerly","year":"2025","journal-title":"Anticancer. Drugs"},{"key":"10.1016\/j.biopha.2026.119692_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119692_bib58","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","article-title":"PGC1\u03b1 expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress","volume":"23","author":"Vazquez","year":"2013","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119692_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1362786","article-title":"Residual OXPHOS is required to drive primary and metastatic lung tumours in an orthotopic breast cancer model","volume":"14","author":"Herst","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119692_bib60","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41388-023-02596-8","article-title":"Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment","volume":"42","author":"Baek","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119692_bib61","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/jcp.29160","article-title":"Malate-aspartate shuttle promotes l-lactate oxidation in mitochondria","volume":"235","author":"Altinok","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2026.119692_bib62","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s42255-022-00642-5","article-title":"HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma","volume":"4","author":"Chen","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2026.119692_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70255","article-title":"A Unique Intercellular Feedforward Loop From HK1 to TGF-\u03b21 Promotes the Progression of Hepatocellular Carcinoma","volume":"15","author":"Chen","year":"2026","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biopha.2026.119692_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100852","article-title":"The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications","volume":"63","author":"Icard","year":"2022","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.biopha.2026.119692_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216677","article-title":"PP4R1 promotes glycolysis and gallbladder cancer progression through facilitating ERK1\/2 mediated PKM2 nuclear translocation","volume":"586","author":"He","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119692_bib66","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.7150\/thno.103722","article-title":"A novel pathway for stemness propagation and chemoresistance in non-small cell lung cancer via phosphorylated PKM2-loaded small extracellular vesicles","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119692_bib67","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i3.103450","article-title":"Hypoxia-inducible factor 1-alpha and lactate dehydrogenase-A axis in metabolic changes and aggression in esophageal squamous-cell carcinoma","volume":"17","author":"Chen","year":"2025","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.biopha.2026.119692_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112945","article-title":"HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1","volume":"42","author":"Yang","year":"2023","journal-title":"Cell. Rep."},{"key":"10.1016\/j.biopha.2026.119692_bib69","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1074\/jbc.M109950200","article-title":"Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis","volume":"277","author":"Pastorino","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119692_bib70","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.15252\/embj.201490379","article-title":"Aerobic glycolysis tunes YAP\/TAZ transcriptional activity","volume":"34","author":"Enzo","year":"2015","journal-title":"Embo J."},{"key":"10.1016\/j.biopha.2026.119692_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118215","article-title":"The expression and role of glycolysis-associated molecules in infantile hemangioma","volume":"259","author":"Chen","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2026.119692_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216964","article-title":"Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation","volume":"593","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119692_bib73","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","article-title":"PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis","volume":"150","author":"Yang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119692_bib74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41419-025-07391-9","article-title":"GP73-mediated secretion of PKM2 and GP73 promotes angiogenesis and M2-like macrophage polarization in hepatocellular carcinoma","volume":"16","author":"Wang","year":"2025","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119692_bib75","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1111\/cas.70202","article-title":"Epigenetic Regulation of G6PD Drives Metabolic Reprogramming in Intrahepatic Cholangiocarcinoma","volume":"116","author":"Nakano","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2026.119692_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41389-023-00464-4","article-title":"The p52-ZER6\/G6PD axis alters aerobic glycolysis and promotes tumor progression by activating the pentose phosphate pathway","volume":"12","author":"Tang","year":"2023","journal-title":"Oncogenesis"},{"key":"10.1016\/j.biopha.2026.119692_bib77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/HP.S99044","article-title":"Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells","volume":"4","author":"Zimmer","year":"2016","journal-title":"Hypoxia (Auckl. )"},{"key":"10.1016\/j.biopha.2026.119692_bib78","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13578-025-01455-1","article-title":"AFF4 promotes tumor progression and cisplatin resistance by modulating the PTEN\/PI3K\/AKT\/mTOR axis to accelerate glycolysis in lung adenocarcinoma","volume":"15","author":"Yao","year":"2025","journal-title":"Cell. Biosci."},{"key":"10.1016\/j.biopha.2026.119692_bib79","first-page":"2754","article-title":"Metabolome Analysis Reveals Excessive Glycolysis via PI3K\/AKT\/mTOR and RAS\/MAPK Signaling in Methotrexate-Resistant Primary CNS Lymphoma-Derived Cells","volume":"26","author":"Takashima","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119692_bib80","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41419-025-07879-4","article-title":"ERCC6L-mediated stabilization of HIF-1\u03b1 enhances glycolysis and stemness properties of lung adenocarcinoma cells","volume":"16","author":"Lu","year":"2025","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119692_bib81","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2003193118","article-title":"Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis","volume":"118","author":"Chibaya","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119692_bib82","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/vco.12979","article-title":"Identification of hypoxia-induced metabolism-associated genes in canine tumours","volume":"22","author":"Kato","year":"2024","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.biopha.2026.119692_bib83","article-title":"The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Attenuates Colon Cancer Development by Regulating Glucose Metabolism","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.biopha.2026.119692_bib84","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-022-02252-1","article-title":"TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1\u03b1 degradation","volume":"41","author":"Chen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119692_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.168072","article-title":"Multiverse of phosphorglycerate kinase: Exploring canonical, moonlighting, and tumor microenvironmental functions","volume":"1872","author":"Kuo","year":"2026","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2026.119692_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101076","article-title":"The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities","volume":"58","author":"Cordani","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.biopha.2026.119692_bib87","article-title":"Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancer","volume":"6","author":"Tailor","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.biopha.2026.119692_bib88","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-023-05793-3","article-title":"Spatial mapping of mitochondrial networks and bioenergetics in lung cancer","volume":"615","author":"Han","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119692_bib89","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1101\/sqb.2016.81.030940","article-title":"Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations","volume":"81","author":"Allen","year":"2016","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.biopha.2026.119692_bib90","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1158\/0008-5472.CAN-23-2700","article-title":"Integrin \u03b1v\u03b23 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic Plasticity","volume":"84","author":"Nam","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119692_bib91","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10863-015-9628-6","article-title":"P. Je\u017eek, Aglycemia keeps mitochondrial oxidative phosphorylation under hypoxic conditions in HepG2 cells","volume":"47","author":"Plecit\u00e1-Hlavat\u00e1","year":"2015","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.biopha.2026.119692_bib92","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2023.05.097","article-title":"Lactic acidosis switches cancer cells from dependence on glycolysis to OXPHOS and renders them highly sensitive to OXPHOS inhibitors","volume":"671","author":"Zeng","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08589-1","article-title":"Lactylation stabilizes PD-L1 to promote tumor immune evasion and cell growth","volume":"17","author":"Liang","year":"2026","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119692_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108957","article-title":"EP300 restores the glycolytic activity and anti-tumor function of CD8(+) cytotoxic T cells in nasopharyngeal carcinoma","volume":"27","author":"Xia","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2026.119692_bib95","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/srep16082","article-title":"Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119692_bib96","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/ac7372","article-title":"Spatiotemporal feedforward between PKM2 tetramers and mTORC1 prompts mTORC1 activation","volume":"19","author":"Xia","year":"2022","journal-title":"Phys. Biol."},{"key":"10.1016\/j.biopha.2026.119692_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040862","article-title":"Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK","volume":"12","author":"Moldogazieva","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119692_bib98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","article-title":"AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo","volume":"17","author":"Faubert","year":"2013","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119692_bib99","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1158\/1541-7786.MCR-12-0669-T","article-title":"Energy management by enhanced glycolysis in G1-phase in human colon cancer cells in vitro and in vivo","volume":"11","author":"Bao","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119692_bib100","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.cell.2024.03.006","article-title":"A glycolytic metabolite bypasses \"two-hit\" tumor suppression by BRCA2","volume":"187","author":"Kong","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119692_bib101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41422-020-0372-z","article-title":"Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle","volume":"31","author":"Liu","year":"2021","journal-title":"Cell. Res."},{"key":"10.1016\/j.biopha.2026.119692_bib102","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1186\/s12885-025-14644-5","article-title":"SKP2 ubiquitylation modifies IDH1 to regulate hepatoblastoma cell cycle and glucose metabolism","volume":"25","author":"Yu","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119692_bib103","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/s41467-019-13485-8","article-title":"Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2018.06.006","article-title":"Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling","volume":"28","author":"Luo","year":"2018","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119692_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215617","article-title":"GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer","volume":"534","author":"Shen","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119692_bib106","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41586-024-08258-3","article-title":"Dietary fructose enhances tumour growth indirectly via interorgan lipid transfer","volume":"636","author":"Fowle-Grider","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119692_bib107","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1038\/onc.2017.227","article-title":"Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer","volume":"36","author":"Ju","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119692_bib108","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41556-025-01655-4","article-title":"Mitochondrial NADPH fuels mitochondrial fatty acid synthesis and lipoylation to power oxidative metabolism","volume":"27","author":"Kim","year":"2025","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119692_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241511969","article-title":"Glucose Deprivation Induces Cancer Cell Death through Failure of ROS Regulation","volume":"24","author":"Kang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119692_bib110","first-page":"2615","article-title":"Multiple post-translational modifications regulate E-cadherin transport during apoptosis","volume":"125","author":"Geng","year":"2012","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.biopha.2026.119692_bib111","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yexcr.2018.01.024","article-title":"O-GlcNAcylation affects \u03b2-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer","volume":"364","author":"Harosh-Davidovich","year":"2018","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.biopha.2026.119692_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110889","article-title":"B3GNT5 is a novel marker correlated with malignant phenotype and poor outcome in pancreatic cancer","volume":"27","author":"Yao","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2026.119692_bib113","doi-asserted-by":"crossref","first-page":"262","DOI":"10.21873\/invivo.13076","article-title":"Aberrant Expression of Solute Carrier Family 35 Member A2 Correlates With Tumor Progression in Breast Cancer","volume":"37","author":"Liu","year":"2023","journal-title":"Vivo"},{"key":"10.1016\/j.biopha.2026.119692_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202400216","article-title":"FOXA2 Loss in TGF-\u03b21-Induced EMT Suppresses Bisecting-GlcNAc N-Glycan Synthesis in Lung Adenocarcinoma","volume":"25","author":"Ge","year":"2025","journal-title":"Proteomics"},{"key":"10.1016\/j.biopha.2026.119692_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003284","article-title":"Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response","volume":"23","author":"Qiu","year":"2025","journal-title":"PLoS. Biol."},{"key":"10.1016\/j.biopha.2026.119692_bib116","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","article-title":"CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors","volume":"21","author":"Wang","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2026.119692_bib117","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fonc.2020.00807","article-title":"S. Romero-Garcia, Lactic Acidosis in the Presence of Glucose Diminishes Warburg Effect in Lung Adenocarcinoma Cells","volume":"10","author":"Prado-Garcia","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119692_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114409","article-title":"Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance","volume":"43","author":"Stigliani","year":"2024","journal-title":"Cell. Rep."},{"key":"10.1016\/j.biopha.2026.119692_bib119","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1158\/0008-5472.CAN-22-3398","article-title":"BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance","volume":"83","author":"Shu","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119692_bib120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yexcr.2018.07.041","article-title":"Paracrine HGF\/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP\/HIF-1\u03b1","volume":"371","author":"Yan","year":"2018","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.biopha.2026.119692_bib121","first-page":"399","article-title":"HIF-1\u03b1 contributes to hypoxia-induced invasion and metastasis of esophageal carcinoma via inhibiting E-cadherin and promoting MMP-2 expression","volume":"66","author":"Jing","year":"2012","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.biopha.2026.119692_bib122","article-title":"Hypoxic Exosomal circPLEKHM1-Mediated Crosstalk between Tumor Cells and Macrophages Drives Lung Cancer Metastasis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.biopha.2026.119692_bib123","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41419-024-06801-8","article-title":"Necroptosis stimulates interferon-mediated protective anti-tumor immunity","volume":"15","author":"Rucker","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119692_bib124","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1128\/MCB.00688-08","article-title":"The JmjC domain histone demethylase Ndy1 regulates redox homeostasis and protects cells from oxidative stress","volume":"28","author":"Polytarchou","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119692_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080798","article-title":"Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression","volume":"8","author":"Crispo","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119692_bib126","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s42255-019-0043-x","article-title":"NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism","volume":"1","author":"Chen","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2026.119692_bib127","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1038\/s41388-021-01673-0","article-title":"c-Src facilitates tumorigenesis by phosphorylating and activating G6PD","volume":"40","author":"Ma","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119692_bib128","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1038\/s41467-020-17839-5","article-title":"Pancreatic cancers suppress negative feedback of glucose transport to reprogram chromatin for metastasis","volume":"11","author":"Bechard","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib129","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41419-025-07903-7","article-title":"PDK1-dependent metabolic reprogramming regulates stemness and tumorigenicity of osteosarcoma stem cells through ATF3","volume":"16","author":"Tokumura","year":"2025","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119692_bib130","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1038\/s41467-020-18954-z","article-title":"Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells","volume":"11","author":"Valle","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib131","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/0008-5472.CAN-17-2726","article-title":"Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells","volume":"78","author":"Zhou","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119692_bib132","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2018.01.075","article-title":"Nuclear translocation of PKM2\/AMPK complex sustains cancer stem cell populations under glucose restriction stress","volume":"421","author":"Yang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119692_bib133","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12935-019-0845-7","article-title":"Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells","volume":"19","author":"Lin","year":"2019","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.biopha.2026.119692_bib134","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.cmet.2024.07.011","article-title":"Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma","volume":"36","author":"Li","year":"2024","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119692_bib135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cac2.12392","article-title":"Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives","volume":"43","author":"Fang","year":"2023","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.biopha.2026.119692_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217917","article-title":"Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer","volume":"631","author":"He","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119692_bib137","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/pros.21172","article-title":"Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies","volume":"70","author":"Stein","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2026.119692_bib138","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrurol.2010.234","article-title":"Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC","volume":"8","author":"Yamasaki","year":"2011","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.biopha.2026.119692_bib139","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-015-3386-3","article-title":"Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing","volume":"151","author":"Wu","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2026.119692_bib140","doi-asserted-by":"crossref","first-page":"32670","DOI":"10.1021\/acsami.9b09886","article-title":"Antitumor Effect of Lonidamine-Polypeptide-Peptide Nanoparticles in Breast Cancer Models","volume":"11","author":"Cohen-Erez","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2026.119692_bib141","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002800050460","article-title":"Pharmacokinetics and toxicity of oral and intravenous lonidamine in dogs","volume":"38","author":"Price","year":"1996","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119692_bib142","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.acra.2006.09.059","article-title":"Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model","volume":"14","author":"Chang","year":"2007","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.biopha.2026.119692_bib143","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/030089169207800215","article-title":"Phase II study with lonidamine in the treatment of hormone-refractory prostatic cancer patients","volume":"78","author":"Boccardo","year":"1992","journal-title":"Tumori"},{"key":"10.1016\/j.biopha.2026.119692_bib144","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mehy.2017.01.014","article-title":"The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view","volume":"100","author":"El Sayed","year":"2017","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2026.119692_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051161","article-title":"The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells","volume":"9","author":"Cal","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119692_bib146","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41559-023-02255-x","article-title":"Drug dependence in cancer is exploitable by optimally constructed treatment holidays","volume":"8","author":"Maltas","year":"2024","journal-title":"Nat. Ecol. Evol."},{"key":"10.1016\/j.biopha.2026.119692_bib147","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1038\/s41598-022-10168-1","article-title":"2 deoxy-D-glucose augments the mitochondrial respiratory chain in heart","volume":"12","author":"Aiestaran-Zelaia","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119692_bib148","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/10915818251340393","article-title":"Nonclinical Safety Evaluation of 2-Deoxy-D-Glucose Following Twice-Daily Oral Administration for 28 Days in Beagle Dogs","volume":"44","author":"Nandre","year":"2025","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.biopha.2026.119692_bib149","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpb.2020.10.016","article-title":"Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model","volume":"157","author":"Sengel-Turk","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2026.119692_bib150","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1039\/D2TB02728C","article-title":"A mitochondria-targeting self-assembled carrier-free lonidamine nanodrug for redox-activated drug release to enhance cancer chemotherapy","volume":"11","author":"Yang","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2026.119692_bib151","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1124\/jpet.113.206714","article-title":"Regulation of death induction and chemosensitizing action of 3-bromopyruvate in myeloid leukemia cells: energy depletion, oxidative stress, and protein kinase activity modulation","volume":"348","author":"Calvi\u00f1o","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119692_bib152","first-page":"2233","article-title":"3-Bromopyruvic Acid Inhibits Tricarboxylic Acid Cycle and Glutaminolysis in HepG2 Cells","volume":"36","author":"Jardim-Messeder","year":"2016","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.biopha.2026.119692_bib153","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ijc.31868","article-title":"Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers","volume":"144","author":"Mondal","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119692_bib154","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1289\/ehp.1002554","article-title":"The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine--both or neither?","volume":"119","author":"Stacpoole","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.biopha.2026.119692_bib155","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/mc.23920","article-title":"Therapeutic Targeting of the Pentose Phosphate Pathway in Colorectal Cancer Using 6-Aminonicotinamide and 5-Fluorouracil","volume":"64","author":"Cheikh","year":"2025","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2026.119692_bib156","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1021\/acsmedchemlett.2c00404","article-title":"Effects of 6-Aminonicotinic Acid Esters on the Reprogrammed Epigenetic State of Distant Metastatic Pancreatic Carcinoma","volume":"13","author":"Gao","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2026.119692_bib157","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1038\/s41598-022-12827-9","article-title":"Pyruvate kinase M1 regulates butyrate metabolism in cancerous colonocytes","volume":"12","author":"Park","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119692_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30173457","article-title":"Metabolism, a Blossoming Target for Small-Molecule Anticancer Drugs","volume":"30","author":"Puxeddu","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119692_bib159","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1186\/s12885-024-13186-6","article-title":"Exploring the impact of mitochondrial-targeting anthelmintic agents with GLUT1 inhibitor BAY-876 on breast cancer cell metabolism","volume":"24","author":"Schumacher","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119692_bib160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41420-024-02106-z","article-title":"GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells","volume":"10","author":"Miller","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.biopha.2026.119692_bib161","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119692_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2026.178893","article-title":"Mitochondrial dysfunction and senescence accompany glioblastoma cell death triggered by a putative metabolic inhibitor","volume":"1024","author":"Yadav","year":"2026","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119692_bib163","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10637-015-0221-y","article-title":"A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors","volume":"33","author":"Chu","year":"2015","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.biopha.2026.119692_bib164","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s10637-013-0047-4","article-title":"Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors","volume":"32","author":"Dunbar","year":"2014","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.biopha.2026.119692_bib165","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00280-010-1391-0","article-title":"2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion","volume":"67","author":"Xi","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119692_bib166","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12986-017-0178-2","article-title":"Press-pulse: a novel therapeutic strategy for the metabolic management of cancer","volume":"14","author":"Seyfried","year":"2017","journal-title":"Nutr. Metab. (Lond. )"},{"key":"10.1016\/j.biopha.2026.119692_bib167","article-title":"Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models","volume":"49","author":"Boreel","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.biopha.2026.119692_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2025.108919","article-title":"Pharmacometric and Digital Twin modeling for adaptive scheduling of combination therapy in advanced gastric cancer","volume":"270","author":"Prunella","year":"2025","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.biopha.2026.119692_bib169","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf9096","article-title":"Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival","volume":"8","author":"Whitburn","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119692_bib170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1535-7163.MCT-07-0482","article-title":"Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth","volume":"7","author":"Clem","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2026.119692_bib171","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41388-024-03035-y","article-title":"ULK1-dependent phosphorylation of PKM2 antagonizes O-GlcNAcylation and regulates the Warburg effect in breast cancer","volume":"43","author":"Zhou","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119692_bib172","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314128121","article-title":"KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis","volume":"121","author":"Xie","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119692_bib173","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174587","article-title":"The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer","volume":"134","author":"Ju","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2026.119692_bib174","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41467-024-44772-8","article-title":"AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to glycolysis for tumorigenesis","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119692_bib175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-025-02334-4","article-title":"Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications","volume":"11","author":"Wang","year":"2026","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119692_bib176","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1038\/s41388-025-03495-w","article-title":"Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells","volume":"44","author":"Tarrado-Castellarnau","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119692_bib177","article-title":"Metabolic classification suggests the GLUT1\/ALDOB\/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer","volume":"4","author":"Li","year":"2023","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.biopha.2026.119692_bib178","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115343","article-title":"Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis","volume":"14","author":"Guyon","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2026.119692_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202206851","article-title":"Biomineralized Two-Enzyme Nanoparticles Regulate Tumor Glycometabolism Inducing Tumor Cell Pyroptosis and Robust Antitumor Immunotherapy","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119692_bib180","article-title":"Pyruvate Kinase M2-Responsive Release of Paclitaxel and Indoleamine 2,3-Dioxygenase Inhibitor for Immuno-Chemotherapy of Nonsmall Cell Lung Cancer","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.biopha.2026.119692_bib181","article-title":"Spatial profiling of the metabolism-immune axis in ovarian cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119692_bib182","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/mrm.27644","article-title":"A novel bioreactor for combined magnetic resonance spectroscopy and optical imaging of metabolism in 3D cell cultures","volume":"81","author":"Cox","year":"2019","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.biopha.2026.119692_bib183","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.celrep.2019.03.029","article-title":"HIF-1\u03b1 is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of Tregs in glioblastoma","volume":"27","author":"Miska","year":"2019","journal-title":"Cell. Rep."},{"key":"10.1016\/j.biopha.2026.119692_bib184","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molcel.2014.09.025","article-title":"Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport","volume":"56","author":"Yang","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.biopha.2026.119692_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112616","article-title":"Endogenous PP2A inhibitor CIP2A degradation by chaperone-mediated autophagy contributes to the antitumor effect of mitochondrial complex I inhibition","volume":"42","author":"Cazzoli","year":"2023","journal-title":"Cell. Rep."},{"key":"10.1016\/j.biopha.2026.119692_bib186","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2049-3002-1-18","article-title":"LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancer","volume":"1","author":"Dupuy","year":"2013","journal-title":"Cancer Metab."},{"key":"10.1016\/j.biopha.2026.119692_bib187","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cell.2022.12.024","article-title":"Light modulates glucose metabolism by a retina-hypothalamus-brown adipose tissue axis","volume":"186","author":"Meng","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119692_bib188","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn5345","article-title":"Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism","volume":"8","author":"Huang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119692_bib189","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202402543","article-title":"Identification of novel target DCTPP1 for colorectal cancer therapy with the natural small-molecule inhibitors regulating metabolic reprogramming","volume":"63","author":"Feng","year":"2024","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biopha.2026.119692_bib190","doi-asserted-by":"crossref","DOI":"10.1126\/science.adp4120","article-title":"Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling","volume":"387","author":"Ding","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119692_bib191","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s12276-024-01268-1","article-title":"PHGDH: a novel therapeutic target in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119692_bib192","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1016\/j.cell.2021.10.001","article-title":"Glycogen accumulation and phase separation drives liver tumor initiation","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:32:52Z","timestamp":1784529172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":192,"alternative-id":["S0753332226007286"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119692","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Warburg effect and beyond: Glycolytic reprogramming in cancer progression and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119692"}}